Gilead Sciences
GILD
#106
Rank
HK$1.431 T
Marketcap
HK$1,154
Share price
0.17%
Change (1 day)
25.44%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): -HK$20.65

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is -HK$20.40. In 2025 the company made an earnings per share (EPS) of HK$53.76 an increase over its 2024 EPS that were of HK$2.98.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$20.65-138.42%
2025HK$53.761702.63%
2024HK$2.98-91.65%
2023HK$35.7123.98%
2022HK$28.80-25.86%
2021HK$38.854850%
2020HK$0.78-97.64%
2019HK$33.270.9%
2018HK$32.9818.71%
2017HK$27.78-64.88%
2016HK$79.10-18.45%
2015HK$97.0055.28%
2014HK$62.47296.02%
2013HK$15.7717.89%
2012HK$13.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.54-435.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$5.96-129.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$28.02-237.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$234.52-1,249.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$127.29-723.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$44.57-318.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$42.46-308.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$136.00-766.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$9.93-148.67%๐Ÿ‡บ๐Ÿ‡ธ USA